Atlas Trials

Acute Myeloid Leukemia With Gene Mutations

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Myeloid Leukemia With Gene Mutations

RecordFirmDate
CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT04493164)M.D. Anderson Cancer Center2020-12-30
Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine (NCT03588078)Groupe Francophone des Myelodysplasies2018-09-15
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486)Roswell Park Cancer Institute2017-12-07
Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation (NCT02634827)Mayo Clinic2015-12-30
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT01904136)M.D. Anderson Cancer Center2014-04-22
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies (NCT01760655)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2012-12-24
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib (NCT03746912)Daiichi Sankyo

Track Acute Myeloid Leukemia With Gene Mutations automatically

Every clearance here is in the API, with alerts when new ones post.